Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 87

1.

Putative Role of Circulating Human Papillomavirus DNA in the Development of Primary Squamous Cell Carcinoma of the Middle Rectum: A Case Report.

Ambrosio MR, Vernillo R, De Carolis S, Carducci A, Mundo L, Ginori A, Rocca BJ, Nardone V, Lucenti Fei A, Carfagno T, Lazzi S, Cricca M, Tosi P.

Front Oncol. 2019 Feb 21;9:93. doi: 10.3389/fonc.2019.00093. eCollection 2019.

3.

Human papilloma virus 16 E6 oncoprotein associated with p53 inactivation in colorectal cancer.

Chen TH, Huang CC, Yeh KT, Chang SH, Chang SW, Sung WW, Cheng YW, Lee H.

World J Gastroenterol. 2012 Aug 14;18(30):4051-8. doi: 10.3748/wjg.v18.i30.4051.

4.

Expression of p16(INK4A), p53, and Rb proteins are independent from the presence of human papillomavirus genes in oral squamous cell carcinoma.

Nemes JA, Deli L, Nemes Z, Márton IJ.

Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2006 Sep;102(3):344-52. Epub 2006 Mar 20.

PMID:
16920543
5.

Human papillomavirus type 16 (HPV-16) virus-like particle L1-specific CD8+ cytotoxic T lymphocytes (CTLs) are equally effective as E7-specific CD8+ CTLs in killing autologous HPV-16-positive tumor cells in cervical cancer patients: implications for L1 dendritic cell-based therapeutic vaccines.

Bellone S, El-Sahwi K, Cocco E, Casagrande F, Cargnelutti M, Palmieri M, Bignotti E, Romani C, Silasi DA, Azodi M, Schwartz PE, Rutherford TJ, Pecorelli S, Santin AD.

J Virol. 2009 Jul;83(13):6779-89. doi: 10.1128/JVI.02443-08. Epub 2009 Apr 22.

6.
7.

Tissue distribution of human papillomavirus 16 DNA integration in patients with tonsillar carcinoma.

Begum S, Cao D, Gillison M, Zahurak M, Westra WH.

Clin Cancer Res. 2005 Aug 15;11(16):5694-9.

8.

Detection of transcriptionally active high-risk HPV in patients with head and neck squamous cell carcinoma as visualized by a novel E6/E7 mRNA in situ hybridization method.

Bishop JA, Ma XJ, Wang H, Luo Y, Illei PB, Begum S, Taube JM, Koch WM, Westra WH.

Am J Surg Pathol. 2012 Dec;36(12):1874-82. doi: 10.1097/PAS.0b013e318265fb2b.

10.

Suppression of Antitumor Immune Responses by Human Papillomavirus through Epigenetic Downregulation of CXCL14.

Cicchini L, Westrich JA, Xu T, Vermeer DW, Berger JN, Clambey ET, Lee D, Song JI, Lambert PF, Greer RO, Lee JH, Pyeon D.

MBio. 2016 May 3;7(3). pii: e00270-16. doi: 10.1128/mBio.00270-16.

11.

Comprehensive T-cell immunophenotyping and next-generation sequencing of human papillomavirus (HPV)-positive and HPV-negative head and neck squamous cell carcinomas.

Poropatich K, Fontanarosa J, Swaminathan S, Dittmann D, Chen S, Samant S, Zhang B.

J Pathol. 2017 Nov;243(3):354-365. doi: 10.1002/path.4953. Epub 2017 Oct 6.

PMID:
28771750
12.

Systemic and local human papillomavirus 16-specific T-cell immunity in patients with head and neck cancer.

Heusinkveld M, Goedemans R, Briet RJ, Gelderblom H, Nortier JW, Gorter A, Smit VT, Langeveld AP, Jansen JC, van der Burg SH.

Int J Cancer. 2012 Jul 15;131(2):E74-85. doi: 10.1002/ijc.26497. Epub 2011 Nov 19.

13.

Verrucous carcinomas of the head and neck, including those with associated squamous cell carcinoma, lack transcriptionally active high-risk human papillomavirus.

Patel KR, Chernock RD, Zhang TR, Wang X, El-Mofty SK, Lewis JS Jr.

Hum Pathol. 2013 Nov;44(11):2385-92. doi: 10.1016/j.humpath.2013.07.011. Epub 2013 Sep 24.

PMID:
24071016
14.

Human papillomavirus in oropharyngeal squamous cell carcinoma: assessing virus presence in normal tissue and activity in cervical metastasis.

Laborde RR, Janus JR, Olsen SM, Wang VW, Garcia JJ, Graham RP, Moore EJ, Olsen KD, Kasperbauer JL, Price DL, Berres M, Halling G, Smith DI.

Laryngoscope. 2012 Dec;122(12):2707-11. doi: 10.1002/lary.23516. Epub 2012 Sep 7.

PMID:
22961429
15.
16.

The presence and prognostic significance of human papillomavirus in squamous cell carcinoma of the larynx.

Erkul E, Yilmaz I, Narli G, Babayigit MA, Gungor A, Demirel D.

Eur Arch Otorhinolaryngol. 2017 Jul;274(7):2921-2926. doi: 10.1007/s00405-017-4573-0. Epub 2017 Apr 21.

PMID:
28439692
17.

The role of human papillomavirus in p16-positive oral cancers.

Belobrov S, Cornall AM, Young RJ, Koo K, Angel C, Wiesenfeld D, Rischin D, Garland SM, McCullough M.

J Oral Pathol Med. 2018 Jan;47(1):18-24. doi: 10.1111/jop.12649. Epub 2017 Oct 30.

PMID:
29024035
18.

Human papillomavirus DNA and p16 expression in Japanese patients with oropharyngeal squamous cell carcinoma.

Kawakami H, Okamoto I, Terao K, Sakai K, Suzuki M, Ueda S, Tanaka K, Kuwata K, Morita Y, Ono K, Nishio K, Nishimura Y, Doi K, Nakagawa K.

Cancer Med. 2013 Dec;2(6):933-41. doi: 10.1002/cam4.151. Epub 2013 Oct 27.

19.

B7-H1 expression model for immune evasion in human papillomavirus-related oropharyngeal squamous cell carcinoma.

Ukpo OC, Thorstad WL, Lewis JS Jr.

Head Neck Pathol. 2013 Jun;7(2):113-21. doi: 10.1007/s12105-012-0406-z. Epub 2012 Nov 20.

20.

The biomarkers of human papillomavirus infection in tonsillar squamous cell carcinoma-molecular basis and predicting favorable outcome.

Kuo KT, Hsiao CH, Lin CH, Kuo LT, Huang SH, Lin MC.

Mod Pathol. 2008 Apr;21(4):376-86. doi: 10.1038/modpathol.3800979. Epub 2008 Jan 25.

Supplemental Content

Support Center